Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Freeze and desist: Disabling cardiac cells that can cause arrhythmia

13.09.2011
Majority of cryoballoon ablation patients show no signs of a-fib year after procedure

Many patients are responding to a new, minimally invasive way of treating irregular heartbeats by freezing out the bad cells. Atrial fibrillation (A-Fib) is one such heart rhythm disorder, and it's the most common arrhythmia affecting Americans.

However, new research shows that 70 percent of patients with the disorder who were treated with cryoballoon ablation, the freezing technique, are free of any heart rhythm irregularities one year out from having the procedure. These results suggest that this minimally invasive procedure may be faster, safer and more effective than the commonly used approach of burning the cells in order to put the heart back into a normal rhythm pattern.

Northwestern Memorial Hospital is the only hospital in the city of Chicago, and one of only three in the state of Illinois, performing this procedure. According to cardiologist, Bradley Knight, MD, the switch from "hot" to "cold" has been good for patients.

"This novel technology has the potential to help a large number of patients with symptomatic atrial fibrillation," said Knight, director of electrophysiology at Northwestern Memorial Hospital's Bluhm Cardiovascular Institute. "It represents the first major advance in the tools available to us to perform catheter ablation for patients with intermittent atrial fibrillation in over a decade."

Not only is A-Fib the most common heart rhythm disorder, it's one of the most undertreated. Approximately three million Americans are estimated to have the disease. A-Fib results from abnormal electrical impulses in the heart. The irregularity can be continuous, or it can come and go. Some people can become light-headed or faint, and other symptoms include weakness, lack of energy or shortness of breath and chest pain. A big concern for patients with atrial fibrillation is preventing blood clots or stroke. Half of all diagnosed atrial fibrillation patients fail drug therapy, and if left untreated, have up to five times higher risk of stroke and increased chance of developing heart failure.

Catheter ablation procedures for patients with A-Fib are typically performed by delivering radiofrequency energy (heat) through an electrode at the tip of a catheter to cauterize small amounts of heart tissue responsible for A-Fib. The tissue that is targeted is in the left atrium, near the entrance to the pulmonary veins, while using a point-to-point treatment.

"This new technology called cryoballoon, represents a way to perform ablation in two important ways," says Rod Passman, MD, medical director of the program for atrial fibrillation at Northwestern Memorial Hospital's Bluhm Cardiovascular Institute. "The first is that it freezes the heart tissue rather than using heat. Freezing may lead to less disruption of the lining of the heart chamber and might cause less damage to nearby structures like the esophagus compared to heating the tissue. The second way is that the large balloon allows for a much larger area of heart tissue to be ablated at one time. This should prevent gaps in the ablation lines that can occur with point-to-point radiofrequency ablation."

The FDA's approval of the technology used to do this procedure was based on a trial that demonstrated the safety and efficiency of the device in treating A-Fib. The study showed that 70 percent of patients treated with this freezing technique were free of A-fib at one year, compared to 7 percent of patients treated with drug therapy only. The study also demonstrated that patients enrolled in the study displayed a significant reduction of symptoms, a decrease in the use of drug therapy and great improvement in both physical and emotional quality-of-life factors.

For more information about heart care at Northwestern Memorial Hospital, visit our website. To schedule an appointment please call 312-926-0779.

About Northwestern Memorial HealthCare

Northwestern Memorial HealthCare is the parent corporation of Chicago's Northwestern Memorial Hospital, an 854-bed academic medical center hospital and Northwestern Lake Forest Hospital, a 205-bed community hospital located in Lake Forest, Illinois.

About Northwestern Memorial Hospital

Northwestern Memorial is one of the country's premier academic medical center hospitals and is the primary teaching hospital of the Northwestern University Feinberg School of Medicine. Along with its Prentice Women's Hospital and Stone Institute of Psychiatry, the hospital comprises 854 beds, 1,603 affiliated physicians and 7,144 employees. Northwestern Memorial is recognized for providing exemplary patient care and state-of-the art advancements in the areas of cardiovascular care; women's health; oncology; neurology and neurosurgery; solid organ and soft tissue transplants and orthopaedics.

Northwestern Memorial possesses nursing Magnet Status, the nation's highest recognition for patient care and nursing excellence. It is also listed in 13 clinical specialties in U.S. News & World Report's 2011 "America's Best Hospitals" guide and ranks No. 1 in Chicago in the 2011 U.S. News & World Report Best Hospitals metro area rankings. For 10 years running, Northwestern Memorial has been rated among the "100 Best Companies for Working Mothers" guide by Working Mother magazine. The hospital is a recipient of the prestigious National Quality Health Care Award and has been chosen by Chicagoans as the Consumer Choice according to the National Research Corporation's annual survey for 11 years.

Todd Medland | EurekAlert!
Further information:
http://www.nmh.org

More articles from Health and Medicine:

nachricht Hot cars can hit deadly temperatures in as little as one hour
24.05.2018 | Arizona State University

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

When corals eat plastics

24.05.2018 | Ecology, The Environment and Conservation

Surgery involving ultrasound energy found to treat high blood pressure

24.05.2018 | Medical Engineering

First chip-scale broadband optical system that can sense molecules in the mid-IR

24.05.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>